Rest Of Asia Pacific Organ Preservation Market (2025-2030)
The Rest Of Asia Pacific Organ Preservation Market was valued at $19.27 Million in 2025 and projected to reach to $23.88 Million by 2030, representing a compound annual growth rate of 4.4%. Rest Of Asia Pacific's organ preservation market is positioned for consistent growth as healthcare systems modernize and transplant programs expand across the region.
Rest Of Asia Pacific Organ Preservation Market Trends and Insights
- Rest Of Europe's organ preservation sector is expanding at a compound annual growth rate of 4.4%, driven by increasing demand for advanced preservation technologies and improved transplant outcomes.
- Rest Of Europe continues to invest in healthcare infrastructure and organ transplantation programs, supporting the adoption of innovative preservation solutions across the region. Rest Of Europe's market growth reflects broader European trends toward enhanced organ viability and reduced transplant rejection rates.
- Rest Of Europe's healthcare systems are increasingly recognizing the clinical and economic benefits of advanced preservation techniques, including hypothermic and normothermic perfusion systems.
- Rest Of Europe's regulatory environment and collaborative transplant networks are facilitating market expansion, positioning the region as a key player in the global organ preservation landscape through 2030..
Key Market Statistics
- CAGR (2025-2030) 4.4% CAGR
- Market Size, 2025 ~USD 19.27 Million
- Forecast, 2030 ~USD 23.88 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Organ Preservation Market Overview
Market Size & Growth :
Rest Of Asia Pacific's organ preservation market is valued at $19.27 million in 2025, expanding to $23.88 million by 2030, representing a steady 4.4% CAGR driven by improving healthcare infrastructure and transplant demand.
Technology Adoption :
Emerging economies in Rest Of Asia Pacific are increasingly adopting advanced organ preservation technologies, including hypothermic machine perfusion and normothermic preservation systems, to enhance transplant success rates.
Healthcare Investment :
Rising government healthcare spending and private sector investments in Rest Of Asia Pacific are accelerating the development of transplant centers and organ preservation capabilities across the region.
Transplant Demand Drivers :
Growing prevalence of organ failure diseases, aging populations, and improved access to transplant procedures in Rest Of Asia Pacific countries are fueling demand for reliable organ preservation solutions.
Rest Of Asia Pacific Organ Preservation Market Dynamics
- The 4.4% CAGR reflects increasing adoption of preservation technologies among developing healthcare economies seeking to improve transplant outcomes and reduce organ wastage.
- Government initiatives and private healthcare investments are strengthening transplant infrastructure, creating opportunities for preservation solution providers. The market outlook remains positive through 2030, supported by rising organ transplant volumes, enhanced regulatory frameworks, and growing awareness of preservation technology benefits.
- Rest Of Asia Pacific's emerging markets present significant growth potential as they transition toward advanced preservation methods, though adoption rates vary by country development level and healthcare system maturity..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Rest Of Europe's organ preservation market is valued at $19.27 million in 2025 and is forecast to grow to $23.88 million by 2030.
- Rest Of Europe is experiencing a 4.4% CAGR, reflecting steady adoption of advanced preservation technologies across the region.
- Rest Of Europe's healthcare systems are increasingly investing in organ transplantation infrastructure and preservation innovation.
- Rest Of Europe's collaborative transplant networks and regulatory frameworks are supporting sustainable market growth through 2030.
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
Rest Of Asia Pacific Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Manufacturers of organ preservation equipment and solutions need Rest Of Asia Pacific market data to identify expansion opportunities, understand regional demand for preservation technologies, and develop localized product strategies.
- Healthcare Investors & PE Firms : Investment professionals require detailed market analysis of Rest Of Asia Pacific's organ preservation sector to evaluate investment returns, assess market growth potential, and identify acquisition targets in emerging healthcare markets.
- Hospital & Transplant Center Operators : Transplant program administrators need market insights to benchmark their preservation capabilities against regional standards, justify capital investments in new technologies, and optimize organ utilization rates.
- Healthcare Consultants & Advisors : Consulting firms advising healthcare clients in Rest Of Asia Pacific require market data to develop strategic recommendations, assess competitive positioning, and guide clients through technology adoption decisions.
- Government & Healthcare Policy Makers : Policymakers in Rest Of Asia Pacific countries need market intelligence to inform healthcare infrastructure investments, establish transplant program standards, and develop regulations supporting organ preservation advancement.
Key Companies in the Rest Of Asia Pacific Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Reasons to Buy this Report
- Regional Market Insights : Gain detailed understanding of Rest Of Asia Pacific's organ preservation market dynamics, including country-specific growth patterns, adoption rates, and competitive landscape unique to emerging Asian economies.
- Investment Opportunity Assessment : Identify high-potential markets within Rest Of Asia Pacific for expansion, partnership, or acquisition based on comprehensive market sizing, growth forecasts, and healthcare infrastructure development trends.
- Technology Adoption Trends : Understand which preservation technologies are gaining traction in Rest Of Asia Pacific, including machine perfusion systems and normothermic solutions, to align product development and marketing strategies.
- Competitive Positioning : Benchmark your organization against regional competitors in Rest Of Asia Pacific, identify market gaps, and develop targeted strategies to capture growing demand for organ preservation solutions.
- Regulatory & Market Entry Strategy : Access critical information on healthcare regulations, reimbursement policies, and market entry barriers specific to Rest Of Asia Pacific countries to inform business development and go-to-market planning.
Frequently asked questions
What is the current market size of organ preservation in Rest Of Europe?
Rest Of Europe's organ preservation market is estimated at $19.27 million in 2025.
What is the projected market size for Rest Of Europe by 2030?
Rest Of Europe's organ preservation market is forecast to reach $23.88 million by 2030.
What is the CAGR for Rest Of Europe's organ preservation market?
Rest Of Europe's organ preservation market is growing at a compound annual growth rate of 4.4% from 2025 to 2030.
What factors are driving growth in Rest Of Europe's organ preservation market?
Rest Of Europe's market growth is driven by increased healthcare investment, adoption of advanced preservation technologies, and improved transplant outcomes.
How does Rest Of Europe's organ preservation market compare to global trends?
Rest Of Europe's 4.4% CAGR reflects steady regional growth, supported by collaborative transplant networks and regulatory frameworks that facilitate innovation adoption.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report